HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
HER2-Targeted Tyrosine Kinase Inhibitors Cause Therapy-Induced-Senescence in Breast Cancer Cells
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 2, Pages 197
Publisher
MDPI AG
Online
2019-02-11
DOI
10.3390/cancers11020197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- First results from the phase III ALTTO trial (BIG 2-06; NCCTG [Alliance] N063D) comparing one year of anti-HER2 therapy with lapatinib alone (L), trastuzumab alone (T), their sequence (T→L), or their combination (T+L) in the adjuvant treatment of HER2-positive early breast cancer (EBC).
- (2017) Martine J. Piccart-Gebhart et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiosensitizing effect of lapatinib in human epidermal growth factor receptor 2-positive breast cancer cells
- (2016) Tosol Yu et al. Oncotarget
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
- (2014) Evandro de Azambuja et al. LANCET ONCOLOGY
- PP2A inhibition overcomes acquired resistance to HER2 targeted therapy
- (2014) Martina SJ McDermott et al. Molecular Cancer
- A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis
- (2013) M Kracikova et al. CELL DEATH AND DIFFERENTIATION
- Autophagy stimulates apoptosis in HER2-overexpressing breast cancers treated by lapatinib
- (2013) Xingmei Zhu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Drug rechallenge and treatment beyond progression—implications for drug resistance
- (2013) Elizabeth A. Kuczynski et al. Nature Reviews Clinical Oncology
- Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
- (2012) José Baselga et al. LANCET
- The impact of cellular senescence in cancer therapy: is it true or not?
- (2011) Yi Zhang et al. ACTA PHARMACOLOGICA SINICA
- EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks
- (2011) M. Wang et al. CANCER RESEARCH
- Irreversible Protein Kinase Inhibitors
- (2011) L. Garuti et al. CURRENT MEDICINAL CHEMISTRY
- p53 and p16INK4A independent induction of senescence by chromatin-dependent alteration of S-phase progression
- (2011) Alexandre Prieur et al. Nature Communications
- Therapy-Induced Senescence in Cancer
- (2010) Jonathan A. Ewald et al. JNCI-Journal of the National Cancer Institute
- MLN8054, an Inhibitor of Aurora A Kinase, Induces Senescence in Human Tumor Cells Both In vitro and In vivo
- (2010) J. J. Huck et al. MOLECULAR CANCER RESEARCH
- Rechallenging with anthracyclines and taxanes in metastatic breast cancer
- (2010) Carlo Palmieri et al. Nature Reviews Clinical Oncology
- Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor-Positive Metastatic Breast Cancer
- (2010) L. S. Schwartzberg et al. ONCOLOGIST
- Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2
- (2009) Paolo Spallarossa et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- PRIMA-1 Reactivates Mutant p53 by Covalent Binding to the Core Domain
- (2009) Jeremy M.R. Lambert et al. CANCER CELL
- Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
- (2009) L. Liu et al. CANCER RESEARCH
- Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo
- (2009) Florence Debacq-Chainiaux et al. Nature Protocols
- Drug-induced senescence bystander proliferation in prostate cancer cells in vitro and in vivo
- (2008) J A Ewald et al. BRITISH JOURNAL OF CANCER
- A Prostatic Intraepithelial Neoplasia-Dependent p27Kip1 Checkpoint Induces Senescence and Inhibits Cell Proliferation and Cancer Progression
- (2008) Pradip K. Majumder et al. CANCER CELL
- Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy
- (2008) Pierre-Emmanuel Puig et al. CELL BIOLOGY INTERNATIONAL
- BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
- (2008) D Li et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started